CANADA, October 2 2019 (ANALYTICALCANNABIS) Researchers at Western University, Canada, have uncovered the exact molecular mechanisms that cause CBD to block some of the negative psychiatric side effects associated with high levels of THC in cannabis.
Their study, the results of which were recently published in the Journal of Neuroscience, identified extracellular-signal regulated...
AUSTRALIA, Ocotber 8, 2019, (CANNABISNOW) In the decades since the medical marijuana movement began in earnest in the 1970s, cannabis has been anecdotally touted as an effective treatment for a variety of illnesses, including those impacting brain function, such as seizures, anxiety and depression. However, peer-reviewed research into the...
U.S, December 21, 2019 (INDEPENDENT) Thousands of people with severe epilepsy will be able to access a cannabis-based treatment on the NHS from the new year, it has been revealed.
Epidyolex, a cannabidiol (CBD) oral medication, has been fast-tracked by the health service in England to be available from 6...
U.S, February 12, 2020 (CANNABISTECH) Solving bioavailability issues with cannabinoids, nanoemulsion technology and ultrasonic techniques increase product effectiveness.
Cannabis has always had an issue with bioavailability. Whether smoked, eaten, or applied, each method of delivery loses a significant percentage of medicinal or...
US, November 1, 2019 (HEMPGAZETTE) A $1 million U.S. Department of Agriculture grant is supporting Purdue University research into organic hemp production.
Much knowledge has been lost in the USA between the start of prohibition decades ago and the recent hemp renaissance; particularly in relation to growing hemp without the...
CANADA, February 4, 2020 (HEMPINDUSTRY) Editor’s note: This is part of an occasional series on retailing trends in the hemp industry.
Canada’s federal health regulator is reviewing the potential market for cannabis health products that would not require physician oversight, a review that...